Novo Nordisk Total Liabilities 1988-2025 | NVO
Novo Nordisk total liabilities from 1988 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Novo Nordisk total liabilities for the quarter ending June 30, 2025 were $47.773B, a 28.89% increase year-over-year.
- Novo Nordisk total liabilities for 2024 were $46.735B, a 54.8% increase from 2023.
- Novo Nordisk total liabilities for 2023 were $30.191B, a 35.14% increase from 2022.
- Novo Nordisk total liabilities for 2022 were $22.34B, a 13.46% increase from 2021.
| Novo Nordisk Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $46,735 |
| 2023 | $30,191 |
| 2022 | $22,340 |
| 2021 | $19,691 |
| 2020 | $12,501 |
| 2019 | $10,196 |
| 2018 | $9,010 |
| 2017 | $7,981 |
| 2016 | $7,767 |
| 2015 | $6,671 |
| 2014 | $6,556 |
| 2013 | $4,945 |
| 2012 | $4,326 |
| 2011 | $5,093 |
| 2010 | $4,357 |
| 2009 | $3,560 |
| 2008 | $3,279 |
| 2007 | $2,861 |
| 2006 | $2,448 |
| 2005 | $2,392 |
| 2004 | $1,825 |
| 2003 | $1,398 |
| 2002 | $1,204 |
| 2001 | $1,042 |
| 2000 | $1,109 |
| 1999 | $1,065 |
| 1998 | $14,055 |
| 1997 | $1,140 |
| 1996 | $1,076 |
| 1995 | $1,164 |
| 1994 | |